ATP7A and colorectal carcinoma: When copper supplementation is provided, elesclomol binds extracellular and cytoplastic copper and brings them to mitochondria, leading to severe death of CRC cells through ROS accumulation and consequent ferroptosis, which requires the loss of ATP7A.